Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Finazzi

Showing results (111-120 of 132) with videos related to

Pageof 14
Sort By:
Thrombosis and Haemostasis|February 3, 1992
Markers of procoagulant imbalance in patients with inherited thrombophilic syndromesP M Mannucci, A Tripodi, B Bottasso, et al.
British Journal of Haematology|August 1, 1993
Identification of nine novel mutations in type I antithrombin deficiency by heteroduplex screeningV Chowdhury, R J Olds, D A Lane, et al.
Thrombosis and Haemostasis|September 28, 2011
Questions and answers on the use of dabigatran and perspectives on the use of other new oral anticoagulants in patients with atrial fibrillation. A consensus document of the Italian Federation of Thrombosis Centers (FCSA)V Pengo, L Crippa, A Falanga, et al.
Journal of Thrombosis and Haemostasis : JTH|May 5, 2005
A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS)G Finazzi, R Marchioli, V Brancaccio, et al.
Journal of Food Protection|November 7, 2012
Quantitative risk assessment of verocytotoxin-producing Escherichia coli O157 and Campylobacter jejuni related to consumption of raw milk in a province in Northern ItalyF Giacometti, A Serraino, P Bonilauri, et al.
British Journal of Haematology|February 13, 2001
Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use studyR Chopra, J D Eaton, A Grassi, et al.
Bone Marrow Transplantation|February 10, 2015
Allo-SCT for myelofibrosis: reversing the chronic phase in the JAK inhibitor era?R Tamari, T I Mughal, D Rondelli, et al.
Acta Neurologica Scandinavica|August 19, 2000
Recurrence after first cerebral infarction in young adultsM Camerlingo, L Casto, B Censori, et al.
Journal of Thrombosis and Haemostasis : JTH|July 26, 2012
Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent resultsV Pengo, L Crippa, A Falanga, et al.
Thrombosis Research|May 11, 2016
PO-19 - Platelet (PLT) adhesion under flow condition in essential thrombocythemia (ET) and polycythemia vera (PV) is variably influenced according to patient mutational statusA Vignoli, S Tessarolo, M Marchetti, et al.
Pageof 14

Showing results (111-120 of 132) with videos related to

Sort By:
Pageof 14
Thrombosis and Haemostasis|February 3, 1992
Markers of procoagulant imbalance in patients with inherited thrombophilic syndromesP M Mannucci, A Tripodi, B Bottasso, et al.
British Journal of Haematology|August 1, 1993
Identification of nine novel mutations in type I antithrombin deficiency by heteroduplex screeningV Chowdhury, R J Olds, D A Lane, et al.
Thrombosis and Haemostasis|September 28, 2011
Questions and answers on the use of dabigatran and perspectives on the use of other new oral anticoagulants in patients with atrial fibrillation. A consensus document of the Italian Federation of Thrombosis Centers (FCSA)V Pengo, L Crippa, A Falanga, et al.
Journal of Thrombosis and Haemostasis : JTH|May 5, 2005
A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS)G Finazzi, R Marchioli, V Brancaccio, et al.
Journal of Food Protection|November 7, 2012
Quantitative risk assessment of verocytotoxin-producing Escherichia coli O157 and Campylobacter jejuni related to consumption of raw milk in a province in Northern ItalyF Giacometti, A Serraino, P Bonilauri, et al.
British Journal of Haematology|February 13, 2001
Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use studyR Chopra, J D Eaton, A Grassi, et al.
Bone Marrow Transplantation|February 10, 2015
Allo-SCT for myelofibrosis: reversing the chronic phase in the JAK inhibitor era?R Tamari, T I Mughal, D Rondelli, et al.
Acta Neurologica Scandinavica|August 19, 2000
Recurrence after first cerebral infarction in young adultsM Camerlingo, L Casto, B Censori, et al.
Journal of Thrombosis and Haemostasis : JTH|July 26, 2012
Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent resultsV Pengo, L Crippa, A Falanga, et al.
Thrombosis Research|May 11, 2016
PO-19 - Platelet (PLT) adhesion under flow condition in essential thrombocythemia (ET) and polycythemia vera (PV) is variably influenced according to patient mutational statusA Vignoli, S Tessarolo, M Marchetti, et al.
Pageof 14